Post Marketing Information PEM 19/05/2025 ULTOMIRIS® (ravulizumab): Guide for Healthcare Professionals PMG 19/05/2025 ULTOMIRIS® (ravulizumab): Guide for Patients/Parents/Caregivers PAC 19/05/2025 ULTOMIRIS® PATIENT CARD: Important Safety Information for Patients Taking ULTOMIRIS® (ravulizumab)
INTRAVENOUS Select a brand starting with the letter: U ULTOMIRIS CONCENTRATE FOR SOLUTION FOR INFUSION 100 MG/ML [SIN17026P]